FA
ABBV icon

Fountainhead AM’s AbbVie ABBV Stock Holding History

Fountainhead AM’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$602K Buy
2,391
+399
+20% +$85.8K 0.45% 47
2026
Q1 		$433K Buy
1,992
+727
+57% +$161K 0.39% 52
2025
Q4 		$289K Sell
1,265
-1,788
-59% -$407K 0.43% 47
2025
Q3 		$707K Buy
3,053
+941
+45% +$192K 0.09% 92
2025
Q2 		$392K Sell
2,112
-29
-1% -$5.39K 0.06% 134
2025
Q1 		$449K Buy
2,141
+359
+20% +$69.8K 0.07% 102
2024
Q4 		$317K Buy
1,782
+330
+23% +$60.7K 0.06% 118
2024
Q3 		$287K Sell
1,452
-65
-4% -$12.1K 0.06% 112
2024
Q2 		$260K Sell
1,517
-104
-6% -$17.2K 0.06% 107
2024
Q1 		$295K Buy
1,621
+13
+0.8% +$2.24K 0.07% 95
2023
Q4 		$249K Buy
1,608
+17
+1% +$2.48K 0.07% 95
2023
Q3 		$237K Buy
+1,591
New +$234K 0.08% 78
2023
Q2 		– Sell
-1,475
Closed -$235K – 85
2023
Q1 		$235K Sell
1,475
-39
-3% -$5.96K 0.09% 65
2022
Q4 		$245K Buy
+1,514
New +$232K 0.11% 56
2022
Q3 		– Sell
-1,308
Closed -$200K – 77
2022
Q2 		$200K Buy
1,308
+12
+0.9% +$1.83K 0.11% 65
2022
Q1 		$210K Buy
+1,296
New +$188K 0.09% 69

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fountainhead AM's ABBV Position: Q2 2026 in Review

Fountainhead AM increased its AbbVie (ABBV) stake by 20% in Q2 2026, buying an estimated $85.8K and bringing the position to 2,391 shares worth $602K. The position accounts for 0.45% of the portfolio, ranked #47.

Fountainhead AM first reported a position in ABBV in Q1 2022 and has held it in 16 quarters since. The position peaked at $707K in Q3 2025. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Fountainhead AM held 2,391 shares of AbbVie worth $602K as of Q2 2026.
  • Fountainhead AM bought 399 AbbVie shares in Q2 2026, an estimated $85.8K.
  • AbbVie made up 0.45% of Fountainhead AM's portfolio in Q2 2026, its #47 holding.
  • Fountainhead AM first reported a position in AbbVie in Q1 2022 and has held it in 16 quarters since.
  • Fountainhead AM's AbbVie position peaked at $707K in Q3 2025.
  • 4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fountainhead AM's 13F filing for Q2 2026, filed 3 Aug 2026.